Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Rosuvastatin
Drug ID BADD_D01971
Description Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America.[A181087, A181406]
Indications and Usage Used as an adjunct to dietary therapy to treat primary hyperlipidemia (heterozygous familial and nonfamilial), mixed dyslipidemia and hypertriglyceridemia. Also indicated for homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering therapies or when other such therapies are not available. Furthermore, it is used to slow the progression of atherosclerosis and for primary prevention of cardiovascular disease.
Marketing Status Prescription
ATC Code C10AA07
DrugBank ID DB01098
KEGG ID D08492
MeSH ID D000068718
PubChem ID 446157
TTD Drug ID D0JE2E
NDC Product Code 47335-986; 31722-883; 49252-064; 47335-985; 50268-710; 16729-285; 70518-1601; 50268-709; 71335-1446; 47335-984; 69238-1148; 68382-629; 71335-0749; 61919-786; 16729-286; 50090-3177; 16729-284; 50268-711; 70771-1484; 31722-882; 50090-2724; 31722-884; 68071-2326; 31722-885; 70518-1219; 70771-1482; 70771-1481; 49252-062; 70518-0986; 70771-1483; 71335-0606; 50228-117; 47335-987; 68382-628; 68382-627; 16729-287; 68788-7971; 50228-118; 50228-119; 49252-061; 68788-7673; 50228-116; 50090-4909; 72189-065; 49252-063; 50090-2725; 69238-1147; 70269-400; 69238-1146; 71205-044; 68382-630; 70518-1384; 69238-1149
Synonyms Rosuvastatin Calcium | Calcium, Rosuvastatin | Crestor | Rosuvastatin | ZD4522 | ZD 4522
Chemical Information
Molecular Formula C22H28FN3O6S
CAS Registry Number 287714-41-4
SMILES CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blood creatinine increased13.13.01.0040.000883%
Blood glucose decreased13.02.02.0010.000132%Not Available
Blood glucose increased13.02.02.0020.000397%Not Available
Blood lactate dehydrogenase increased13.04.02.0020.000132%
Blood potassium decreased13.11.01.010--Not Available
Blood potassium increased13.11.01.0110.000177%Not Available
Blood pressure decreased13.14.03.002--Not Available
Blood pressure diastolic increased13.14.03.0040.000132%Not Available
Blood pressure fluctuation24.06.01.0020.000088%Not Available
Blood pressure increased13.14.03.005--Not Available
Blood testosterone decreased13.10.05.0040.000177%Not Available
Blood thyroid stimulating hormone increased13.10.03.0060.000353%
Blood triglycerides increased13.12.03.0010.000574%Not Available
Blood urea increased13.13.01.0060.000265%Not Available
Body temperature increased13.15.01.0010.000088%Not Available
Bone pain15.02.01.001--
Bradycardia02.03.02.0020.000927%Not Available
Bradypnoea22.02.01.0020.000088%Not Available
Breast cancer21.05.01.003; 16.10.01.001--Not Available
Breast enlargement21.05.04.0010.000221%Not Available
Breast pain21.05.05.0030.000221%
Breast tenderness21.05.05.0040.000088%Not Available
Breath odour07.01.06.0020.000132%Not Available
Bronchiectasis22.03.02.0050.000088%Not Available
Bronchitis22.07.01.001; 11.01.09.001--
Bronchospasm10.01.03.012; 22.03.01.0040.000132%
Bundle branch block right02.03.01.0110.000088%Not Available
Burning sensation17.02.06.001; 08.01.09.0290.000353%Not Available
Bursitis15.04.01.0010.000088%Not Available
C-reactive protein increased13.09.01.0070.000353%Not Available
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 22 Pages